• Mon, October 30, 2023

by: WOPRAI

Marc Riddick Upgraded (CBZ) to Strong Buy and Held Target at $63 on, Oct 30th, 2023

by: WOPRAI

Raghuram Selvaraju Maintained (BCPC) at Strong Buy with Decreased Target to $135 on, Oct 30th, 2023

by: WOPRAI

Andrew Cooper Maintained (AVTR) at Buy with Decreased Target to $23 on, Oct 30th, 2023

by: WOPRAI

Luke Sergott Maintained (AVTR) at Buy with Decreased Target to $21 on, Oct 30th, 2023

by: WOPRAI

Tejas Savant Maintained (AVTR) at Buy with Decreased Target to $22 on, Oct 30th, 2023

by: WOPRAI

David Feaster Maintained (AX) at Buy with Decreased Target to $45 on, Oct 30th, 2023

by: WOPRAI

Vincent Anderson Maintained (ASH) at Strong Buy with Decreased Target to $110 on, Oct 30th, 2023

by: WOPRAI

Elyse Greenspan Downgraded (AON) to Sell and Decreased Target to $304 on, Oct 30th, 2023

by: WOPRAI

Paul Newsome Maintained (AON) at Hold with Decreased Target to $318 on, Oct 30th, 2023

by: WOPRAI

Scott Heleniak Maintained (AON) at Hold with Decreased Target to $342 on, Oct 30th, 2023

by: WOPRAI

Michael Ward Reiterated (AN) at Strong Buy and Held Target at $200 on, Oct 30th, 2023

by: WOPRAI

Christopher Glynn Maintained (B) at Buy with Decreased Target to $30 on, Oct 30th, 2023

by: WOPRAI

Bruno Amorim Maintained (AZUL) at Strong Buy with Decreased Target to $16 on, Oct 30th, 2023

by: WOPRAI

Joseph Moore Maintained (AEVA) at Hold with Decreased Target to $4.4 on, Oct 30th, 2023

by: WOPRAI

Vincent Andrews Maintained (ADM) at Hold with Decreased Target to $76 on, Oct 30th, 2023

by: WOPRAI

Nathan Race Maintained (ALRS) at Hold with Decreased Target to $19 on, Oct 30th, 2023

by: WOPRAI

Michael Leithead Maintained (AMBP) at Buy with Decreased Target to $4 on, Oct 30th, 2023

by: WOPRAI

Joseph Moore Maintained (AMBA) at Buy with Decreased Target to $65 on, Oct 30th, 2023

by: WOPRAI

Casey Orr Whitman Maintained (WSBC) at Hold with Decreased Target to $26 on, Oct 30th, 2023

by: WOPRAI

Paul Quinn Maintained (WFG) at Buy with Decreased Target to $95 on, Oct 30th, 2023

by: WOPRAI

Walter Spracklin Reiterated (WCN) at Buy and Held Target at $164 on, Oct 30th, 2023

by: WOPRAI

Joseph Pantginis Maintained (VYNE) at Strong Buy with Decreased Target to $5.75 on, Oct 30th, 2023

by: WOPRAI

Kinngai Chan Upgraded (WDC) to Strong Buy on, Oct 30th, 2023

by: WOPRAI

Ramsey El-Assal Maintained (WEX) at Buy with Decreased Target to $225 on, Oct 30th, 2023

by: WOPRAI

Chris Shibutani Maintained (BMY) at Strong Buy with Decreased Target to $69 on, Oct 30th, 2023

by: WOPRAI

Todd Brooks Reiterated (BJRI) at Strong Buy and Held Target at $41 on, Oct 30th, 2023

by: WOPRAI

Nicole Miller Regan Maintained (BJRI) at Hold with Decreased Target to $28 on, Oct 30th, 2023

by: WOPRAI

Jed Kelly Reiterated (BKNG) at Buy on, Oct 30th, 2023

by: WOPRAI

Michael Cyprys Maintained (VRTS) at Sell with Increased Target to $170 on, Oct 30th, 2023

by: WOPRAI

Patrick Tyler Brown Maintained (VMC) at Buy with Decreased Target to $225 on, Oct 30th, 2023

by: WOPRAI

Lucas Ward Initiated (VMAR) at Strong Buy and Held Target at $68 on, Oct 30th, 2023

by: WOPRAI

Steven Alexopoulos Downgraded (VLY) to Hold and Decreased Target to $10 on, Oct 30th, 2023

by: WOPRAI

Matthew Breese Maintained (VLY) at Hold with Decreased Target to $8 on, Oct 30th, 2023

by: WOPRAI

Bruno Amorim Maintained (VLRS) at Strong Buy with Decreased Target to $13 on, Oct 30th, 2023

by: WOPRAI

Tim Moore Initiated (VNRX) at Strong Buy and Held Target at $4.5 on, Oct 30th, 2023

by: WOPRAI

Serge Belanger Maintained (VRDN) at Strong Buy with Decreased Target to $30 on, Oct 30th, 2023

by: WOPRAI

Jonathan Block Maintained (ZTS) at Strong Buy with Decreased Target to $195 on, Oct 30th, 2023

by: WOPRAI

Nathan Race Maintained (BSVN) at Buy with Decreased Target to $27 on, Oct 30th, 2023

by: WOPRAI

Raimo Lenschow Maintained (V) at Buy with Decreased Target to $278 on, Oct 30th, 2023

by: WOPRAI

Paul Newsome Maintained (UVE) at Buy with Increased Target to $21 on, Oct 30th, 2023

by: WOPRAI

Cai Rumohr Maintained (TXT) at Buy and Held Target at $86 on, Oct 30th, 2023

by: WOPRAI

Nick McKay Reiterated (TTWO) at Buy and Held Target at $165 on, Oct 30th, 2023

by: WOPRAI

Daina Graybosch Downgraded (TSVT) to Hold on, Oct 30th, 2023

by: WOPRAI

Nathan Martin Reiterated (ARLP) at Strong Buy and Held Target at $28 on, Oct 30th, 2023

by: WOPRAI

Joseph Feldman Reiterated (ARHS) at Buy and Held Target at $15 on, Oct 30th, 2023

by: WOPRAI

Ravi Shanker Maintained (ARCB) at Buy with Increased Target to $145 on, Oct 30th, 2023

by: WOPRAI

J. Bruce Chan Maintained (ARCB) at Strong Buy with Increased Target to $136 on, Oct 30th, 2023

by: WOPRAI

Richard Shane Maintained (ABR) at Sell with Decreased Target to $13 on, Oct 30th, 2023

Joseph Pantginis Maintained (VYNE) at Strong Buy with Decreased Target to $5.75 on, Oct 30th, 2023

Joseph Pantginis of HC Wainwright & Co., Maintained "VYNE Therapeutics Inc." (VYNE) at Strong Buy with Decreased Target from $28 to $5.75 on, Oct 30th, 2023.

Joseph, nor any peers, have made any analyst calls on VYNE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍